Global Antimicrobial Resistance Surveillance Market
Medical Equipment

Antimicrobial Resistance Surveillance Market Dynamics 2026: Future Outlook and Key Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy manufacturing automation market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Antimicrobial Resistance Surveillance Market size between 2026 and 2035?

The antimicrobial resistance surveillance market has experienced substantial growth in recent years. It is forecast to expand from $7.3 billion in 2025 to $7.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.4%. The market’s historical development can be linked to the rise in drug-resistant infections, various hospital infection control initiatives, the establishment of public health surveillance programs, the broadening of laboratory testing, and growing concerns over antibiotic misuse.

The antimicrobial resistance surveillance market size is anticipated to demonstrate robust expansion over the forthcoming years. It is forecast to increase to $10.85 billion by 2030, registering a compound annual growth rate (CAGR) of 8.2%. This projected growth can be ascribed to several factors, including global AMR monitoring initiatives, AI-driven predictive surveillance, cloud-based data sharing, the expansion of genomic surveillance, and policy-driven reporting mandates. Significant trends during this period are expected to feature real-time resistance pattern monitoring, whole genome sequencing surveillance, AI-based resistance analytics, integrated public health databases, and hospital-wide AMR tracking systems.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp

Which Drivers Are Impacting Market Performance In The Antimicrobial Resistance Surveillance Market?

The escalating occurrence of infectious diseases is anticipated to drive the expansion of the antimicrobial resistance surveillance market in the future. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals either directly or indirectly. The increased frequency of infectious diseases stems from elements such as climate change, urbanization, and international travel, all of which facilitate pathogen dissemination and increase human contact with novel microbes. Antimicrobial resistance surveillance aids in monitoring the propagation of resistant pathogens, thereby informing effective treatment approaches and shaping public health directives to counter infectious diseases. For example, a report from the UK Health Security Agency, a UK-based government body, indicated that in February 2024, tuberculosis (TB) cases in England rose by 10.7% in 2023, totaling 4,850 cases versus 4,380 in 2022. Consequently, the growing incidence of infectious diseases is a key factor propelling the expansion of the antimicrobial resistance surveillance market.

Which Segments Are Contributing To The Growth Of The Antimicrobial Resistance Surveillance Market?

The antimicrobial resistance surveillance market covered in this report is segmented –

1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services

2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications

3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users

Subsegments:

1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits

2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems

3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems

4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services

What Trends Are Projected To Support The Growth Of The Antimicrobial Resistance Surveillance Market?

Leading companies in the market are prioritizing innovative technologies, including advanced diagnostic instruments, to streamline operations, enhance efficiency, improve accuracy, reduce expenditures, and achieve superior outcomes for patients and end-users. A diagnostic tool is defined as any device, instrument, software, or method utilized to identify, detect, or assess the presence of a condition, disease, malfunction, or issue. For example, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer and service provider for diagnostic products, announced the introduction of its PA-100 AST Point-of-Care Testing System. This system facilitates the rapid and accurate detection of antimicrobial resistance at the point of care, offering a considerable reduction in processing time compared to conventional laboratory methods, which can extend to several days. By yielding results in just 30 minutes, it enables clinicians to make timely and informed decisions regarding suitable treatments for infections, diminishing the reliance on broad-spectrum antibiotics and assisting in the fight against the spread of antimicrobial resistance.

Who Are The Top-Performing Companies In The Antimicrobial Resistance Surveillance Market In Recent Years?

Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-surveillance-global-market-report

Which Region Currently Holds The Largest Share Of The Antimicrobial Resistance Surveillance Market?

North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Antimicrobial Resistance Surveillance Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Resistance Surveillance Market 2026, By The Business Research Company

Pediatric Orthopedic Implants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report

Orthopedic Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Orthopedic Regenerative Surgical Products Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company